由胆固醇积累引起的细胞衰老是由APOE4和AD中的 lysosomal ABCA1介导的
Shaowei Wang1, Boyang Li1, Jie Li1
1Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
Molecular neurodegeneration
|February 3, 2025
概括
胆固醇的积累驱动阿尔茨海默氏症 (AD) 中的大脑细胞衰老,通过影响ATP结合盒载体A1 (ABCA1) 贩运. 针对这种途径可能为AD提供新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 衰老研究研究 衰老研究
- 分子生物学分子生物学
背景情况:
- 细胞衰老,一个关键的衰老过程,越来越多地与阿尔茨海默氏症 (AD) 病原发生有关.
- 胆固醇积累是已知的细胞衰老的驱动因素,但确切的机制仍然难以捉摸.
- 结合ATP的磁带载体A1 (ABCA1) 对于胆固醇平衡至关重要,并且在AD和APOE4模型中失调,但其在衰老中的作用尚不清楚.
研究的目的:
- 调查ATP结合盒载体A1 (ABCA1) 贩运在与APOE4和阿尔茨海默病 (AD) 相关的细胞衰老中的作用.
- 阐明连接胆固醇代谢,ABCA1和大脑细胞衰老的机制.
主要方法:
- 对人类死后大脑样本 (转录学,组织学,蛋白学) 的分析,以将细胞衰老与ABCA1表达和胆固醇水平相关联.
- 利用ABCA1淘汰细胞系和小鼠模型,以及APOE4-TR小鼠和iPSC模型,研究胆固醇诱导的衰老途径.
- 蛋白质组查确定了caveolin-1作为ABCA1贩运的调解者.
主要成果:
- 阿尔茨海默病的大脑显示老化特征增加,ABCA1表达和氧胆固醇水平增加,与mTOR酸化相关.
- 卡维奥林-1是一种胆固醇传感器,促进了ABCA1内解酶体的贩运,并且在APOE4模型和AD大脑中升高.
- 氧化醇诱导的mTORC1激活和衰老是由ABCA1溶酶体捕获的介导;在APOE4-TR小鼠和人类星体细胞中,循环氨酸治疗改善了这些效应.
结论:
- 在APOE4和AD大脑中氧化醇的积累升级了ABCA1和caveolin-1的调节,导致溶酶体功能障碍和增强细胞衰老.
- 这项研究揭示了胆固醇代谢如何加速大脑细胞衰老,突出了ABCA1和caveolin-1作为潜在的治疗点.
- 针对胆固醇-ABCA1衰老途径提供了一种新的策略,以减轻AD相关的神经炎症和衰老.
相关概念视频
Aging
36
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
36
Alzheimer's Disease: Overview
437
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437
Inflammation
52.4K
Overview
52.4K
Cholesterol: Significance and Regulation
497
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
497
Mitochondria
9.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
9.9K
Alzheimer's Disease: Treatment
158
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
158


